The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Urinary Phthalate Metabolite Concentrations and Diabetes among Women in the National Health and Nutrition Examination Survey (NHANES) 2001–2008
Open accessAbstract
BACKGROUND: Previous studies have shown that women have higher urinary concentrations of several phthalate metabolites than do men, possibly because of a higher use of personal care products. Few studies have evaluated the association between phthalate metabolites, diabetes, and diabetes-related risk factors among women. OBJECTIVE: We explored the association between urinary phthalate metabolite concentrations and diabetes among women who participated in a cross-sectional study. METHODS: We used urinary concentrations of phthalate metabolites, analyzed by the Centers for Disease Control and Prevention, and self-reported diabetes of 2,350 women between 20 and 79 years of age who participated in the NHANES (2001-2008). We used multiple logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs) and adjusted for urinary creatinine, sociodemographic characteristics, dietary factors, and body size. A secondary analysis was conducted for women who did not have diabetes to evaluate the association between phthalate metabolite concentrations and fasting blood glucose (FBG), homeostasis model assessment-estimated insulin resistance, and glycosylated hemoglobin A1c. RESULTS: After adjusting for potential confounders, women with higher levels of mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP), monobenzyl phthalate (MBzP), mono-(3-carboxypropyl) phthalate (MCPP), and three di-(2-ethylhexyl) phthalate metabolites (ΣDEHP) had an increased odds of diabetes compared with women with the lowest levels of these phthalates. Women in the highest quartile for MBzP and MiBP had almost twice the odds of diabetes [OR = 1.96 (95% CI: 1.11, 3.47) and OR = 1.95 (95% CI: 0.99, 3.85), respectively] compared with women in the lowest quartile. Nonmonotonic, positive associations were found for MnBP and ΣDEHP, whereas MCPP appeared to have a threshold effect. Certain phthalate metabolites were positively associated with FBG and insulin resistance. DISCUSSION: Urinary levels of several phthalates were associated with prevalent diabetes. Future prospective studies are needed to further explore these associations to determine whether phthalate exposure can alter glucose metabolism and increase the risk of insulin resistance and diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Trends in Obesity Among US Adults, 1999-2008
Flegal, K. M. (2010) · JAMA · doi:10.1001/jama.2009.2014 · Cited by 7,580 · cited 1×
“Although increased body mass index (BMI) is a major risk factor of diabetes (Colditz et al. 1995; Flegal et al. 2010; Mokdad et al. 2000), other factors are thought to be involved in the type 2 diabetes (T2DM) epidemic (Stahlhut et al. 2007; Svensson et al. 2011; Thayer et al 2012).”
BackgroundBonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Weight gain as a risk factor for clinical diabetes mellitus in women
Colditz, G. A., Willett, W. C., Rotnitzky, A., & Manson, J. E. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-7-199504010-00001 · Cited by 2,064
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042 · cited 2×
“Although increased body mass index (BMI) is a major risk factor of diabetes (Colditz et al. 1995; Flegal et al. 2010; Mokdad et al. 2000), other factors are thought to be involved in the type 2 diabetes (T2DM) epidemic (Stahlhut et al. 2007; Svensson et al. 2011; Thayer et al 2012).”
BackgroundHauser, R., & Calafat, A. M. (2005) · Occupational and Environmental Medicine · doi:10.1136/oem.2004.017590 · Cited by 941
Self-citationEmoto, M., Nishizawa, Y., Maekawa, K., Hiura, Y., Kanda, H., Kawagishi, T., Shoji, T., Okuno, Y., & Morii, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.818 · Cited by 457
Hatch, E. E., Nelson, J. W., Qureshi, M. M., Weinberg, J., Moore, L. L., Singer, M., & Webster, T. F. (2008) · Environmental Health · doi:10.1186/1476-069x-7-27 · Cited by 436 · cited 1×
“In particular, certain types of environmental endocrine-disrupting chemicals (EDCs) have been implicated as having the ability to alter both adiposity and insulin resistance (Hatch et al. 2008; Latini et al. 2009; Newbold 2010; Stahlhut et al. 2007).”
Background
Cited by
Metabolism disrupting chemicals and metabolic disorders
Heindel, J. J., Blumberg, B., Cave, M., Machtinger, R., Mantovani, A., Mendez, M. A., Nadal, A., Palanza, P., Panzica, G., Sargis, R., et al. (2017) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.10.001 · Cited by 1,101
Phthalates impact human health: Epidemiological evidences and plausible mechanism of action
Benjamin, S., Masai, E., Kamimura, N., Takahashi, K., Anderson, R. C., & Faisal, P. A. (2017) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2017.06.036 · Cited by 747
The effects of phthalate ester exposure on human health: A review
Chang, W.-H., Herianto, S., Lee, C.-C., Hung, H., & Chen, H.-L. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.147371 · Cited by 398
Environmental Epigenetics and Its Implication on Disease Risk and Health Outcomes
Ho, S.-M., Johnson, A., Tarapore, P., Janakiram, V., Zhang, X., & Leung, Y.-K. (2012) · ILAR Journal · doi:10.1093/ilar.53.3-4.289 · Cited by 312
Sun, Q., Cornelis, M. C., Townsend, M. K., Tobias, D. K., Eliassen, A. H., Franke, A. A., Hauser, R., & Hu, F. B. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1307201 · Cited by 274
Self-citationKuo, C.-C., Moon, K., Thayer, K. A., & Navas-Acien, A. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0432-6 · Cited by 274
Rich-Edwards, J. W., Kaiser, U. B., Chen, G. L., Manson, J. E., & Goldstein, J. M. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00246 · Cited by 273
Self-citationKim, H., Hu, E. A., & Rebholz, C. M. (2019) · Public Health Nutrition · doi:10.1017/s1368980018003890 · Cited by 262
Endocrine-Disrupting Chemicals and Disease Endpoints
Ahn, C., & Jeung, E.-B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065342 · Cited by 252
Song, Y., Chou, E. L., Baecker, A., You, N. Y., Song, Y., Sun, Q., & Liu, S. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12325 · Cited by 228
Immune System: An Emerging Player in Mediating Effects of Endocrine Disruptors on Metabolic Health
Bansal, A., Henao-Mejia, J., & Simmons, R. A. (2018) · Endocrinology · doi:10.1210/en.2017-00882 · Cited by 152
Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly
Lind, L., Zethelius, B., Salihovic, S., van Bavel, B., & Lind, P. M. (2014) · Diabetologia · doi:10.1007/s00125-013-3126-3 · Cited by 128
Praegnatio Perturbatio—Impact of Endocrine-Disrupting Chemicals
Padmanabhan, V., Song, W., & Puttabyatappa, M. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa035 · Cited by 103
Dirtu, A. C., Geens, T., Dirinck, E., Malarvannan, G., Neels, H., Van Gaal, L., Jorens, P. G., & Covaci, A. (2013) · Environment International · doi:10.1016/j.envint.2013.06.023 · Cited by 86
Metadata
- Authors
- James-Todd, T., Stahlhut, R., Meeker, J. D., Powell, S.-G., Hauser, R., Huang, T., & Rich-Edwards, J.
- Venue
- Environmental Health Perspectives
- Publisher
- American Chemical Society (ACS)
- Published
- 2012-09
- Volume
- 120
- Issue
- 9
- Pages
- 1307-1313
- ISSN
- 0091-6765 (ISSN-L)
- 1552-9924
- OpenAlex
- W2147827078
- Cited by
- 227
- References
- 7
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.